| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.836 | 32.363 | 30.724 | 49.687 | 34.127 | 46.352 | 20.029 | 59.776 | 125.253 | 68.740 |
| Total Income - EUR | 29.836 | 32.363 | 30.724 | 49.688 | 34.127 | 46.352 | 20.029 | 59.776 | 127.703 | 68.751 |
| Total Expenses - EUR | 31.084 | 25.322 | 24.392 | 48.505 | 31.108 | 40.665 | 21.072 | 40.315 | 92.131 | 76.795 |
| Gross Profit/Loss - EUR | -1.248 | 7.042 | 6.332 | 1.183 | 3.019 | 5.687 | -1.043 | 19.461 | 35.572 | -8.044 |
| Net Profit/Loss - EUR | -2.116 | 6.718 | 6.024 | 762 | 2.678 | 5.238 | -1.227 | 18.945 | 34.462 | -8.978 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - M&T Laboratories S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.878 | 3.402 | 1.994 | 661 | 1.224 | 1.126 | 674 | 338 | 0 | 0 |
| Current Assets | 113.693 | 139.798 | 151.372 | 110.374 | 111.553 | 116.723 | 111.403 | 138.030 | 101.563 | 18.307 |
| Inventories | 62 | 17.907 | 17.604 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 110.004 | 115.121 | 133.030 | 109.143 | 110.435 | 116.169 | 111.063 | 136.147 | 90.722 | 17.838 |
| Cash | 3.628 | 6.771 | 738 | 1.230 | 1.118 | 554 | 340 | 1.883 | 10.841 | 468 |
| Shareholders Funds | 68.837 | 74.853 | 79.611 | 78.912 | 80.061 | 83.782 | 80.697 | 99.892 | 46.151 | -8.829 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 67.734 | 68.346 | 73.755 | 39.644 | 36.403 | 34.067 | 31.380 | 38.476 | 55.412 | 27.135 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7120 - 7120" | |||||||||
| CAEN Financial Year |
7120
|
|||||||||
Comments - M&T Laboratories S.r.l.